CBD (Cannabidiol)/THC (Tetrahydrocannabinol) Solution as a Pharmacological Strategy for Patients With Fibromyalgia (FibroCann)
Clinical trial NCT05283161 · UNKNOWN
Trial details
- NCT number
- NCT05283161
- Sponsor
- FG Brasil LTDA
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-15
- Primary completion
- 2022-08-20
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.